Crypto trading is fastest growing segment fueling the growth of Kidney Transplant Market

Key players operating in the kidney transplant market are Sanofi, Pfizer, Inc., Novartis AG., B. Braun Melsungen AG, Fresenius Medical Care, Medtronic, Preservation Solution Inc., TransMedics, Inc., Organ Recovery Systems, and Transonic Systems Inc.

The kidney transplant market comprises products such as immunosuppressant drugs, preservation solutions, nephrostomy catheters, transplant diagnostic/monitoring products. These products play a crucial role in preventing organ rejection after a kidney transplant.

Increasing usage of combination immunosuppressant drugs: Combination immunosuppressant drugs as opposed to single-drug regimens have emerged as the standard of care in kidney transplantation. Combination therapy involves the use of two or more immunosuppressant drugs with different mechanisms of action. This offers greater efficacy and tolerability. Combination immunosuppressant drugs account for a large share of the kidney transplant market.

The global kidney transplant market is dominated by the HLA compatibility segment. HLA compatibility techniques analyze the human leukocyte antigens of the donor and the recipient and match them. This technique is widely adopted as it reduces the body's immune response against transplanted kidneys and the chances of organ rejection. The adoption of HLA matching has increased the success rate of kidney transplants.

The Global Kidney Transplant Market Size is expected to witness high growth, exhibiting a CAGR of 3.1% over the forecast period, due to increasing prevalence of chronic kidney diseases and growing elderly population.

North America dominated the global kidney transplant market in 2023 and is expected to remain the largest market during the forecast period. This is attributed to the increased adoption of kidney transplant procedures, presence of well-established healthcare facilities, and government funding.

Read More


Mais artigos: